Aptose Bioscns (APTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
Operating Expenses | 0 | 2,180 | 2,620 | 1,020 | 0 |
Operating Income | N/A | -2,180 | -2,620 | -1,020 | N/A |
Interest Expense | 0 | 70 | 60 | 30 | 0 |
Other Income | 0 | 10 | -10 | -10 | 0 |
Pre-tax Income | 0 | -2,240 | -2,690 | -1,060 | 0 |
Net Income Continuous | -3,933 | -2,229 | -2,630 | -1,140 | -1,264 |
Net Income | $-3,933 | $-2,229 | $-2,630 | $-1,140 | $-1,264 |
EPS Basic Total Ops | -7.20 | -7.20 | -10.80 | -5.40 | -5.40 |
EPS Basic Continuous Ops | -6.87 | -6.57 | -10.82 | -4.86 | -5.38 |
EPS Diluted Total Ops | -7.20 | -7.20 | -10.80 | -5.40 | -5.40 |
EPS Diluted Continuous Ops | -6.87 | -6.57 | -10.82 | -4.86 | -5.38 |
EBITDA(a) | $N/A | $-2,170 | $-2,616 | $-1,046 | $10 |